Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

Author:

Narita Tomoko1,Ishida Takashi1ORCID,Ito Asahi1,Masaki Ayako12,Kinoshita Shiori1,Suzuki Susumu3,Takino Hisashi2,Yoshida Takashi1,Ri Masaki1,Kusumoto Shigeru1,Komatsu Hirokazu1,Imada Kazunori4,Tanaka Yuetsu5,Takaori-Kondo Akifumi6,Inagaki Hiroshi2,Scholz Arne7,Lienau Philip7,Kuroda Taruho8,Ueda Ryuzo3,Iida Shinsuke1

Affiliation:

1. Department of Hematology and Oncology and

2. Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;

3. Department of Tumor Immunology, School of Medicine, Aichi Medical University, Aichi, Japan;

4. Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan;

5. Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan;

6. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;

7. Bayer AG Pharmaceuticals Division, Berlin, Germany; and

8. Bayer Yakuhin, Ltd, Osaka, Japan

Abstract

Key Points BAY 1143572, a novel and selective P-TEFb/CDK9 inhibitor, possessed significant antitumor activity against primary ATL cells in vitro. BAY 1143572 possessed significant antitumor activity in an ATL mouse model based on tumor cells from a patient.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3